Most of our current knowledge regarding GATA3’s potential function in breast cancer has been revealed from genomic studies highlighting an ER/FOXA1/GATA3 co-operating network of transcription factors in luminal tumours [14] and ER-positive cell line models [34,35,37,42,43]. The gene discussed is GATA3; the disease is breast cancer.